Hepatitis C Vaccine in Production
Cuba begins industrial production of new Hepatitis C vaccine
Published on August 10, 2015
HAVANA, Cuba (ACN) — The Heber-NASVAC vaccine to treat Hepatitis C is among the new productions of the National Centre for Bio-formulas (BIOCEN) located in Bejucal, Mayabeque province in Cuba.
Julio Cesar Portuondo, director of the centre, said that the first batches of the drug are being packaged for trial to get a license and certification of good practice, since patients will receive the drug in liquid applications through the nasal cavity, the Cubasi website reported on Thursday.
Continue reading this entire article:
FDA Grants Priority Review: Once-Daily, Single-Tablet Combination for HCV
Study Finds Connection Between Coffee, Caffeine and Hepatic Fibrosis